
A bandage that stimulates and directs blood vessel growth on the surface of a wound has been developed by researchers.
The bandage, called a "microvascular stamp," contains living cells that deliver growth factors to damaged tissues in a defined pattern. After a week, the pattern of the stamp "is written in blood vessels," the researchers report.
Advertisement
A paper describing the new approach will appear as the January 2012 cover article of the journal Advanced Materials.
"Any kind of tissue you want to rebuild, including bone, muscle or skin, is highly vascularized," said University of Illinois chemical and biomolecular engineering professor Hyunjoon Kong, a co-principal investigator on the study with electrical and computer engineering professor Rashid Bashir. "But one of the big challenges in recreating vascular networks is how we can control the growth and spacing of new blood vessels."
"The ability to pattern functional blood vessels at this scale in living tissue has not been demonstrated before," Bashir said. "We can now write features in blood vessels."
Other laboratories have embedded growth factors in materials applied to wounds in an effort to direct blood vessel growth. The new approach is the first to incorporate live cells in a stamp. These cells release growth factors in a more sustained, targeted manner than other methods, Kong said.
The stamp is nearly 1 centimeter across and is built of layers of a hydrogel made of polyethylene glycol (an FDA-approved polymer used in laxatives and pharmaceuticals) and methacrylic alginate (an edible, Jell-O-like material).The stamp is porous, allowing small molecules to leak through, and contains channels of various sizes to direct the flow of larger molecules, such as growth factors.
Source: Eurekalert
Advertisement
"The ability to pattern functional blood vessels at this scale in living tissue has not been demonstrated before," Bashir said. "We can now write features in blood vessels."
Other laboratories have embedded growth factors in materials applied to wounds in an effort to direct blood vessel growth. The new approach is the first to incorporate live cells in a stamp. These cells release growth factors in a more sustained, targeted manner than other methods, Kong said.
The stamp is nearly 1 centimeter across and is built of layers of a hydrogel made of polyethylene glycol (an FDA-approved polymer used in laxatives and pharmaceuticals) and methacrylic alginate (an edible, Jell-O-like material).The stamp is porous, allowing small molecules to leak through, and contains channels of various sizes to direct the flow of larger molecules, such as growth factors.
Source: Eurekalert
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Research News

Utilizing microparticles for therapy could mark a significant milestone in the fight against multiple sclerosis (MS) and other autoimmune diseases.

A study revealed that children with drug-resistant epilepsy (DRE) had the highest survival rate beyond 10 years when they underwent cranial epilepsy surgery.

From childhood through adolescence, the brain constantly changes, and researchers are making strides in identifying a potential treatment target for neuropsychiatric disorders.

In Japan, babies born in 2022 was also a record low at 770,747, down 40,875 from 2021, revealed data.

Researchers also report first direct evidence supporting main theory for how human memory is consolidated during sleep